Androgens: the hormone that talks to the muscle nucleus

An androgen is a steroid hormone that binds the androgen receptor, a ligand-activated transcription factor. Testosterone is the one the testis writes. Inside some tissues, 5α-reductase turns it into dihydrotestosterone, a tighter ligand. Skeletal muscle is awkward on purpose: it has very little 5α-reductase, so the hormone that actually occupies the muscle receptor is testosterone itself. That is why a drug class people lump together as 'anabolics' is, in the fibre, a nuclear receptor story before it is a gym story. The receptor dimerises, moves to the myonucleus, and sits on androgen-response elements. Genes move. The fibre notices over days, not over a pump.

In short. Testosterone binds a receptor in the muscle cell's nucleus and changes which genes are read. Muscle mostly sees testosterone itself, not the stronger cousin some other tissues make.

What moves is not mysterious, and it is not magic nitrogen. In a fibre, androgens raise muscle protein synthesis and lean on muscle protein breakdown, partly by interfering with glucocorticoid signalling that would otherwise be catabolic. They also wake satellite cells. Sinha-Hikim, Bhasin and colleagues showed, in men given supraphysiological testosterone under trial conditions, more satellite cells and more myonuclei as the fibres grew. Bhasin's 1996 New England Journal of Medicine paper is the one to read before you read a forum: testosterone increased fat-free mass and strength, and the increase was larger when the men also lifted. The drug did not replace the bar. The bar did not replace the hormone in that experiment either. Both were real. The paper is not a recipe.

In short. Androgens speed the building of muscle protein, slow the breakdown, and recruit more stem cells onto the fibre. Lifting still adds something the hormone alone does not fully replace.

The diet correlation is blunt. A hormone that raises synthesis raises the demand for essential amino acids and for energy to pay the ATP bill of building myosin. In a genuine surplus, with protein in the range the protein essay already set — about 1.6 to 2.2 grams per kilogram — more of that synthesis can stay as tissue. In a deep deficit, androgens are better at defending lean mass than at inventing it. You cannot transcribe a myosin heavy chain out of a hormone and an empty fridge. Appetite often rises. Body weight then rises because food rose, and people credit the drug for the meals. Nitrogen balance studies from Kochakian onward are why this is not a metaphor. Nitrogen in, minus nitrogen out, is a crude whole-body integral of what the fibre is doing. It still needs carbon and amino groups from the diet.

In short. If you are not eating enough protein and energy, the hormone has nothing to build with. In a calorie deficit it mainly helps you hold muscle. In a surplus it can help you add it, and only if you also load the fibre.

Oestradiol is part of the same molecule's life, not a side plot. Aromatase converts a share of testosterone to oestradiol. Bone, libido, some IGF-1 signalling and the closing of the growth plates all listen to that oestrogen. Crushing it to zero because a forum is frightened of water retention is how people end up with sore joints and a worse lipid picture, not a purer anabolic signal. Muscle itself is not the main aromatase organ. Adipose tissue is. A heavier body aromatises more. That is physiology, and it is also why 'dry' and 'wet' compounds are a slang map of aromatisation and water, not a second receptor.

In short. Some testosterone becomes oestrogen. You need a little of that for bones, joints and drive. Wiping it out is not a smarter version of the same hormone.

Synthetic androgens — the drugs grouped as anabolic-androgenic steroids — are testosterone with the rings edited so the molecule survives the liver longer, aromatises less or more, or binds the receptor with a different balance of anabolic and androgenic effects in old rat assays. Those assays (levator ani versus prostate) are how the field got the word 'anabolic'. They are not a human safety certificate. Nandrolone, drostanolone, stanozolol, methandienone: different structures, one receptor family, different fingerprints on liver, lipids, hair follicles and the heart. Naming them is not offering them. Patriot Peptides does not sell these medicines. They are controlled drugs. A research-peptide catalogue is a different legal object.

In short. Lab-made versions of testosterone still use the same receptor. They differ in side effects, not in kind. This shop does not sell them.

Selective androgen receptor modulators were an attempt to keep the muscle transcription and lose the prostate and skin transcription. Enobosarm and its cousins bind the same receptor and recruit a different mix of coactivators, in the theory. Cachexia trials showed some lean-mass signal and a side-effect list that did not match the brochure: liver enzymes, lipids, suppression of the body's own testosterone. 'Selective' is a design aim. It is not a promise that the hypothalamic-pituitary-gonadal axis will keep working. The axis reads androgen. Any ligand that looks enough like androgen will quiet GnRH, LH and FSH, and sperm production falls with them. That is suppression. It is not a myth invented to scare beginners.

In short. Drugs designed to hit muscle and spare other organs still switch off your own testosterone if they look enough like it. Selectivity was the hope. Suppression is common anyway.

The fibre types from the previous page still apply. Androgens do not invent a type III fibre. They enlarge the fibres you have, with a bias toward the type II fibres that hypertrophy under load, and they add myonuclei so the larger domain can be served. A person who takes an androgen and does not recruit high-threshold motor units grows less than a person who does, which is the Bhasin result in plain clothes. A person who recruits them and does not eat will not bank the protein. Glycogen still limits repeated hard sets. Creatine still buffers the first seconds of a type IIx effort. The hormone is an amplifier of a programme that already had three inputs: tension, amino acids, energy.

In short. Androgens enlarge the fibres you train, especially the fast ones, and they add nuclei. They do not replace heavy work or food.

Harms are part of the mechanism, not a footnote I am embarrassed to write. The same nuclear receptor in the liver changes HDL and LDL in the wrong direction for arteries. Erythropoiesis rises and haematocrit can climb. The left ventricle sees a pressure and a volume story that is not 'more biceps'. Tendon collagen lags the myosin, so a stronger fibre on the same tendon is a risk. The testes shrink because LH fell. Fertility falls because FSH fell. Women virilise because hair follicles and the voice are androgen tissues too. Adolescents close growth plates early if oestrogen from aromatised androgen arrives too soon. I am not going to write a dose, a cycle length, or a post-cycle plan. Those are medical acts. This is a map of the receptor.

In short. The same hormone that grows muscle can wreck cholesterol, thicken blood, quiet fertility, and load a tendon that has not caught up. This page will not tell you a dose.

Growth hormone is not an androgen. It uses a cytokine receptor and JAK-STAT in the liver, and the muscle mostly hears it as IGF-1. Insulin is not an androgen. It is a storage hormone with a tyrosine kinase receptor. Myostatin is a brake in the TGF-β family. Beta-2 agonists hit a different receptor again and mostly remind the heart it has one. Grouping them as 'PEDs' is a legal and sporting category. It is a bad biology category. The next essay separates those chairs. If you only remember one line from this one, remember that the androgen receptor is a transcription factor in the myonucleus, that food is the substrate, and that the bar decides which fibres get the message.

In short. Testosterone is not growth hormone, not insulin, and not a training plan. It is a signal to the nucleus. Food is the building material.

The research peptides on this site that touch the growth-hormone axis — CJC without DAC, ipamorelin, somatropin, IGF-1 LR3 — are not androgens and do not bind the androgen receptor. They are named here so the categories stay clean. They are sold as laboratory reagents, for in-vitro work, not as a cycle. The protein-and-training essay is still the essay that tells you how leucine and tension build the fibre without any of these molecules.

In short. Nothing in the peptide catalogue is testosterone. The molecules that copy growth hormone are a different receptor, and they are research reagents, not a plan for a person.